Physician profile
Mark A Memo
NPI 1457493231
$20,613.12
in general payments reported to CMS, 2019-2025
58 companies · $7,186 in 2025
The $7,186 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,178 · 2020: $2,836 · 2021: $954 · 2022: $1,391 · 2023: $1,968 · 2024: $5,101 · 2025: $7,186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,772 · Consulting Fee: $3,348 · Travel and Lodging: $2,204 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Honoraria: $700 · Education: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,771.73 |
| Consulting Fee | $3,348.00 |
| Travel and Lodging | $2,204.40 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Honoraria | $700.00 |
| Education | $229.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $4,031.18 | 2019-2025 | |
| Avyxa Pharma, LLC | $3,491.80 | 2025 | |
| Genzyme Corporation | $1,812.45 | 2019-2020 | |
| Astellas Pharma US INC | $1,395.32 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Medtronic, INC. | $1,294.19 | 2021-2025 | Interstim, Altaviva |
| Dendreon Pharmaceuticals LLC | $1,220.49 | 2019-2025 | Provenge |
| Axonics, INC. | $831.35 | 2020-2024 | Axonics, Bulkamid |
| Verity Pharmaceuticals INC. | $811.85 | 2023-2025 | Trelstar |
| Pfizer INC. | $806.27 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $487.31 | 2023-2025 | Orgovyx, Gemtesa |
| Dentsply Ih INC. | $404.46 | 2020-2021 | |
| Janssen Biotech, INC. | $308.12 | 2022-2025 | Erleada, Akeega, Balversa |
| Calyxo, INC. | $242.11 | 2024-2025 | Cvac Aspiration System |
| Myriad Genetic Laboratories, INC. | $233.53 | 2023 | Prolaris |
| Teleflex LLC | $214.10 | 2021-2024 | Urolift |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $212.88 | 2024-2025 | |
| Antares Pharma, INC. | $209.35 | 2019-2025 | Xyosted |
| Novartis Pharmaceuticals Corporation | $198.67 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $186.21 | 2022-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Tolmar, INC. | $181.72 | 2023-2025 | Eligard, Rubraca, Jatenzo |
| Urogen Pharma, INC. | $170.93 | 2021-2024 | Jelmyto |
| Astrazeneca Pharmaceuticals LP | $170.73 | 2020-2025 | Lynparza |
| Blue Earth Diagnostics | $138.90 | 2020-2023 | |
| Allergan, INC. | $122.87 | 2019-2021 | |
| Neotract INC. | $106.19 | 2020 | |
| Myovant Sciences INC. | $102.52 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $99.08 | 2019-2020 | |
| Coloplast Corp | $86.61 | 2019-2024 | |
| Urovant Sciences INC | $83.88 | 2022 | |
| Caldera Medical, INC | $72.20 | 2022-2025 | Desara |
| Laborie Medical Technologies Corp. | $69.43 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Ethicon US, LLC | $66.50 | 2019 | |
| Olympus America INC. | $61.28 | 2024-2025 | Itind System |
| Procept Biorobotics Corporation | $60.39 | 2021-2025 | Aquabeam Robotic System |
| Abbvie INC. | $54.53 | 2019-2024 | |
| Boston Scientific Corporation | $53.08 | 2020-2023 | |
| Celgene Corporation | $42.70 | 2022 | |
| Ambu INC. | $38.58 | 2020 | |
| Pharmaand Gmbh | $37.43 | 2025 | Rubraca |
| Cardinal Health 414 LLC | $35.11 | 2023 | |
| Clovis Oncology, INC. | $32.55 | 2020 | |
| Amgen INC. | $32.07 | 2020-2021 | |
| Progenics Pharmaceuticals, INC. | $31.24 | 2025 | |
| Clarus Therapeutics INC. | $28.90 | 2021 | |
| Accord Healthcare, INC. | $23.48 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $22.81 | 2022 | |
| Endo USA, INC. | $21.28 | 2025 | Xiaflex |
| Bluewind Medical | $19.42 | 2024 | Revi |
| Srs Medical Systems, INC. | $19.29 | 2022 | |
| Davol INC. | $18.85 | 2020 | |
| Caris Mpi, INC. | $18.67 | 2025 | Mi Cancer Seek |
| Coopersurgical, INC. | $15.62 | 2022 | |
| Sun Pharmaceutical Industries INC. | $15.30 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $15.06 | 2023 | Jynarque |
| E.R. Squibb & Sons, L.L.C. | $14.90 | 2025 | Opdivo |
| Photocure INC | $14.55 | 2023 | Cysview |
| Telix Pharmaceuticals | $13.69 | 2024 | Illuccix |
| Healthtronics Stone Solutions, LLC | $9.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Memo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.